ABUS vs CSCO · P/E 5.4, rev $6.2M vs P/E 28, rev $56.65B
Arbutus Biopharma Corp (ABUS) versus Cisco Systems Inc (CSCO) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Cisco Systems Inc (CSCO) is a communication equipment company listed on US. It is led by Chuck Robbins.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CSCO revenue for 2025-07-26 was $56.65B. Net income was $10.18B. CSCO currently screens at market cap $272.29B and trailing P/E 28.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CSCO currently screens at market cap $272.29B and trailing P/E 28.1.
Not investment advice. Open the ABUS and CSCO stock pages for the full models.
Not investment advice.